VERU
USDVeru Inc. Common Stock
$0.653-0.007 (-1.061%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$0.660
High
$0.685
Low
$0.612
Volume
1.69M
Company Fundamentals
Market Cap
95.7M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
2.33M
Exchange
NCM
Currency
USD
52-Week Range
Low $0.45Current $0.653High $1.42
Related News
GlobeNewswire
Veru Reports Positive Safety Results from Phase 2b QUALITY Study: Enobosarm Added to Semaglutide Led to Greater Fat Loss, Preservation of Muscle, and Fewer Gastrointestinal Side Effects Compared to Semaglutide Alone
--Phase 2b QUALITY clinical study topline safety data shows that the enobosarm + semaglutide combination had a positive safety profile compared to semaglutide alone-- --Based on Phase 2b QUALITY trial efficacy and
View more
GlobeNewswire
Veru Reports Fiscal 2025 Second Quarter Financial Results and Clinical Program Progress
--Unblinded safety data from Phase 2b QUALITY study expected in the second quarter of calendar 2025 -- --Topline efficacy and safety data for Phase 2b extension maintenance study expected in the second quarter of
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.